EP1373306A4 - Cytoskelett assoziierte proteine - Google Patents

Cytoskelett assoziierte proteine

Info

Publication number
EP1373306A4
EP1373306A4 EP02757814A EP02757814A EP1373306A4 EP 1373306 A4 EP1373306 A4 EP 1373306A4 EP 02757814 A EP02757814 A EP 02757814A EP 02757814 A EP02757814 A EP 02757814A EP 1373306 A4 EP1373306 A4 EP 1373306A4
Authority
EP
European Patent Office
Prior art keywords
cytoskeletion
associated proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02757814A
Other languages
English (en)
French (fr)
Other versions
EP1373306A2 (de
Inventor
April J A Hafalia
Tom Y Tang
Henry Yue
Farrah A Khan
Craig H Ison
Mariah R Baughn
Bridget A Warren
Brendan M Duggan
Kavitha Thangavelu
Cynthia D Honchell
Yalda Azimzai
Vicki S Elliott
Neil Burford
Li Ding
Huibin Yue
Shanya Becha
Brooke M Emerling
Thomas W Richardson
Soo Yeun Lee
Olga Bandman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of EP1373306A2 publication Critical patent/EP1373306A2/de
Publication of EP1373306A4 publication Critical patent/EP1373306A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP02757814A 2001-03-29 2002-03-25 Cytoskelett assoziierte proteine Withdrawn EP1373306A4 (de)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US28050801P 2001-03-29 2001-03-29
US280508P 2001-03-29
US28132301P 2001-04-03 2001-04-03
US281323P 2001-04-03
US28376901P 2001-04-13 2001-04-13
US283769P 2001-04-13
US28860901P 2001-05-04 2001-05-04
US288609P 2001-05-04
US29051801P 2001-05-10 2001-05-10
US290518P 2001-05-10
US29187001P 2001-05-18 2001-05-18
US291870P 2001-05-18
US29445101P 2001-05-29 2001-05-29
US294451P 2001-05-29
PCT/US2002/009288 WO2002079404A2 (en) 2001-03-29 2002-03-25 Cytoskeleton-associated proteins

Publications (2)

Publication Number Publication Date
EP1373306A2 EP1373306A2 (de) 2004-01-02
EP1373306A4 true EP1373306A4 (de) 2005-07-20

Family

ID=27569565

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02757814A Withdrawn EP1373306A4 (de) 2001-03-29 2002-03-25 Cytoskelett assoziierte proteine

Country Status (5)

Country Link
EP (1) EP1373306A4 (de)
JP (1) JP2004533227A (de)
AU (1) AU2002306879A1 (de)
CA (1) CA2441654A1 (de)
WO (1) WO2002079404A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005505258A (ja) 2001-06-21 2005-02-24 イシス・イノベイション・リミテッド アトピーにおけるａｎｇｅ遺伝子
AU2003228872A1 (en) * 2002-05-10 2003-11-11 Incyte Corporation Cell adhesion and extracellular matrix proteins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017355A2 (en) * 1998-09-18 2000-03-30 Incyte Pharmaceuticals, Inc. Human cytoskeleton associated proteins
WO2000056883A1 (en) * 1999-03-23 2000-09-28 Human Genome Sciences, Inc. 49 human secreted proteins
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017355A2 (en) * 1998-09-18 2000-03-30 Incyte Pharmaceuticals, Inc. Human cytoskeleton associated proteins
WO2000056883A1 (en) * 1999-03-23 2000-09-28 Human Genome Sciences, Inc. 49 human secreted proteins
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BERNAL S D ET AL: "CYTOSKELETON-ASSOCIATED PROTEINS THEIR ROLE AS CELLULAR INTEGRATORS IN THE NEOPLASTIC PROCESS", CRITICAL REVIEWS IN ONCOLOGY-HEMATOLOGY, vol. 3, no. 3, 1985, pages 191 - 204, XP009042995, ISSN: 1040-8428 *
DATABASE EM_PAT 3 February 2004 (2004-02-03), "Sequence 21262 from Patent WO02068579", XP002314716, retrieved from EBI Database accession no. CQ735328 *
SATO H ET AL: "The Genomic Organization of Type I Keratin Genes in Mice", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 56, no. 3, 15 March 1999 (1999-03-15), pages 303 - 309, XP004444979, ISSN: 0888-7543 *

Also Published As

Publication number Publication date
CA2441654A1 (en) 2002-10-10
AU2002306879A1 (en) 2002-10-15
WO2002079404A3 (en) 2003-03-20
WO2002079404A2 (en) 2002-10-10
EP1373306A2 (de) 2004-01-02
JP2004533227A (ja) 2004-11-04

Similar Documents

Publication Publication Date Title
GB0130228D0 (en) Protein
EP1365022A4 (de) Adiponectin-assoziiertes protein
GB0130557D0 (en) Proteins
GB0108079D0 (en) Protein
GB0130720D0 (en) Proteins
EP1437410A4 (de) Neue selenocystein enthaltende proteine
EP1373306A4 (de) Cytoskelett assoziierte proteine
AU2002326909A8 (en) Neurotransmission-associated proteins
GB0130560D0 (en) Proteins
GB0130721D0 (en) Protein
GB0106318D0 (en) Protein
GB0100750D0 (en) Novel proteins
GB0128596D0 (en) Proteins
GB0111303D0 (en) Proteins
GB0130718D0 (en) Proteins
GB0128487D0 (en) Proteins
GB0128374D0 (en) Proteins
GB0126787D0 (en) Proteins
GB0125514D0 (en) Proteins
GB0120557D0 (en) Proteins
GB0114313D0 (en) Proteins
GB0130384D0 (en) Proteins
GB0108895D0 (en) Proteins
GB0108472D0 (en) Proteins
GB0130719D0 (en) Proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030916

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050603

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050728

RIN1 Information on inventor provided before grant (corrected)

Inventor name: JONES, KAREN ANNE

Inventor name: RING, HUIJUN Z.

Inventor name: SWARNAKAR, ANITA

Inventor name: LEE, ERNESTINE A.

Inventor name: GRIFFIN, JENNIFER A.

Inventor name: CHAWLA, NARINDER K.

Inventor name: GIETZEN, KIMBERLY J.

Inventor name: LEE, SALLY

Inventor name: LAL, PREETI G.

Inventor name: BANDMAN, OLGA

Inventor name: LEE, SOO, YEUN

Inventor name: RICHARDSON, THOMAS, W.

Inventor name: EMERLING, BROOKE, M.

Inventor name: BECHA, SHANYA

Inventor name: YUE, HUIBIN

Inventor name: DING, LI

Inventor name: BURFORD, NEIL

Inventor name: ELLIOTT, VICKI, S.

Inventor name: AZIMZAI, YALDA

Inventor name: HONCHELL, CYNTHIA, D.

Inventor name: THANGAVELU, KAVITHA

Inventor name: DUGGAN, BRENDAN, M.

Inventor name: WARREN, BRIDGET, A.

Inventor name: BAUGHN, MARIAH, R.

Inventor name: ISON, CRAIG, H.

Inventor name: KHAN, FARRAH, A.

Inventor name: YUE, HENRY

Inventor name: TANG, TOM, Y.

Inventor name: HAFALIA, APRIL, J., A.